These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11030085)

  • 1. Glucosylated isoflavones as DNA topoisomerase II poisons.
    Martín-Cordero C; López-Lazaro M; Piñero J; Ortiz T; Cortés F; Ayuso MJ
    J Enzyme Inhib; 2000; 15(5):455-60. PubMed ID: 11030085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic compounds from Annonaceus species as DNA topoisomerase I poisons.
    López-Lázaro M; Martín-Cordero C; Bermejo A; Cortes D; Ayuso MJ
    Anticancer Res; 2001; 21(5):3493-7. PubMed ID: 11848514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
    Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
    Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human topoisomerase II by the antitumor metallocenes.
    Mokdsi G; Harding MM
    J Inorg Biochem; 2001 Jan; 83(2-3):205-9. PubMed ID: 11237260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol.
    Yamashita Y; Kawada S; Nakano H
    Biochem Pharmacol; 1990 Feb; 39(4):737-44. PubMed ID: 2154993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II.
    Bridewell DJ; Finlay GJ; Baguley BC
    Cancer Chemother Pharmacol; 1999; 43(4):302-8. PubMed ID: 10071981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.
    Drwal MN; Marinello J; Manzo SG; Wakelin LP; Capranico G; Griffith R
    PLoS One; 2014; 9(12):e114904. PubMed ID: 25489853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex.
    Constantinou AI; Husband A
    Anticancer Res; 2002; 22(5):2581-5. PubMed ID: 12529967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
    Wilstermann AM; Osheroff N
    Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podophyllotoxin aza-analogue, a novel DNA topoisomerase II inhibitor.
    Iida A; Kano M; Kubota Y; Koga K; Tomioka K
    Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):486-9. PubMed ID: 10783066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence selectivity of topoisomerases and topoisomerase poisons.
    Capranico G; Binaschi M
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):185-94. PubMed ID: 9748568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerase II cleavage of telomeres in vitro and in vivo.
    Yoon HJ; Choi IY; Kang MR; Kim SS; Muller MT; Spitzner JR; Chung IK
    Biochim Biophys Acta; 1998 Jan; 1395(1):110-20. PubMed ID: 9434158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.
    Fortune JM; Osheroff N
    Prog Nucleic Acid Res Mol Biol; 2000; 64():221-53. PubMed ID: 10697411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioflavonoids as poisons of human topoisomerase II alpha and II beta.
    Bandele OJ; Osheroff N
    Biochemistry; 2007 May; 46(20):6097-108. PubMed ID: 17458941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Olive Metabolites on DNA Cleavage Mediated by Human Type II Topoisomerases.
    Vann KR; Sedgeman CA; Gopas J; Golan-Goldhirsh A; Osheroff N
    Biochemistry; 2015 Jul; 54(29):4531-41. PubMed ID: 26132160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex.
    Hiasa H; Yousef DO; Marians KJ
    J Biol Chem; 1996 Oct; 271(42):26424-9. PubMed ID: 8824300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iridoids as DNA topoisomerase I poisons.
    Gálvez M; Martín-Cordero C; Ayuso MJ
    J Enzyme Inhib Med Chem; 2005 Aug; 20(4):389-92. PubMed ID: 16206835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.